<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="correction"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26451848</article-id><article-id pub-id-type="pmc">4599832</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0140623</article-id><article-id pub-id-type="publisher-id">PONE-D-15-43172</article-id><article-categories><subj-group subj-group-type="heading"><subject>Correction</subject></subj-group></article-categories><title-group><article-title>Correction: Raltegravir Non-Inferior to Nucleoside Based Regimens in SECOND-LINE Therapy with Lopinavir/Ritonavir over 96 Weeks: A Randomised Open Label Study for the Treatment Of HIV-1 Infection</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Amin</surname><given-names>Janaki</given-names></name></contrib><contrib contrib-type="author"><name><surname>Boyd</surname><given-names>Mark A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kumarasamy</surname><given-names>Nagalingeswaran</given-names></name></contrib><contrib contrib-type="author"><name><surname>Moore</surname><given-names>Cecilia L.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Losso</surname><given-names>Marcello H.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Nwizu</surname><given-names>Chidi A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Mohapi</surname><given-names>Lerato</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kerr</surname><given-names>Stephen J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Sohn</surname><given-names>Annette H.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Teppler</surname><given-names>Hedy</given-names></name></contrib><contrib contrib-type="author"><name><surname>Renjifo</surname><given-names>Boris</given-names></name></contrib><contrib contrib-type="author"><name><surname>Molina</surname><given-names>Jean-Michel</given-names></name></contrib><contrib contrib-type="author"><name><surname>Emery</surname><given-names>Sean</given-names></name></contrib><contrib contrib-type="author"><name><surname>Cooper</surname><given-names>David A.</given-names></name></contrib><contrib contrib-type="author"><collab>SECOND-LINE</collab></contrib></contrib-group><pub-date pub-type="epub"><day>9</day><month>10</month><year>2015</year></pub-date><pub-date pub-type="collection"><year>2015</year></pub-date><pub-date pub-type="pmc-release"><day>9</day><month>10</month><year>2015</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. --><volume>10</volume><issue>10</issue><elocation-id>e0140623</elocation-id><permissions><copyright-statement>&#x000a9; 2015 Amin et al</copyright-statement><copyright-year>2015</copyright-year><copyright-holder>Amin et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:type="simple" xlink:href="pone.0140623.pdf"/><related-article id="d35e147" related-article-type="corrected-article" ext-link-type="doi" xlink:href="10.1371/journal.pone.0118228">
<article-title>Raltegravir Non-Inferior to Nucleoside Based Regimens in SECOND-LINE Therapy with Lopinavir/Ritonavir over 96 Weeks: A Randomised Open Label Study for the Treatment Of HIV-1 Infection</article-title>
</related-article><counts><fig-count count="0"/><table-count count="0"/><page-count count="1"/></counts></article-meta></front><body><p>The group author, SECOND-LINE, was omitted from the author byline and should be listed as the fifteenth author. Please see the full list of contributing authors, as well as their full authorship contributions in the Acknowledgements section of the published article.</p></body><back><ref-list><title>Reference</title><ref id="pone.0140623.ref001"><label>1</label><mixed-citation publication-type="journal">
<name><surname>Amin</surname><given-names>J</given-names></name>, <name><surname>Boyd</surname><given-names>MA</given-names></name>, <name><surname>Kumarasamy</surname><given-names>N</given-names></name>, <name><surname>Moore</surname><given-names>CL</given-names></name>, <name><surname>Losso</surname><given-names>MH</given-names></name>, <name><surname>Nwizu</surname><given-names>CA</given-names></name>, <etal>et al</etal> (<year>2015</year>) <article-title>Raltegravir Non-Inferior to Nucleoside Based Regimens in SECOND-LINE Therapy with Lopinavir/Ritonavir over 96 Weeks: A Randomised Open Label Study for the Treatment Of HIV-1 Infection</article-title>. <source>PLoS ONE</source>
<volume>10</volume>(<issue>2</issue>): <fpage>e0118228</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0118228">10.1371/journal.pone.0118228</ext-link></comment>
<pub-id pub-id-type="pmid">25723472</pub-id></mixed-citation></ref></ref-list></back></article>